ライフサイエンスコーパス: blood lead

1 r which bone lead is a better biomarker than blood lead.

2 or folate deficiency, inflammation, or high blood lead.

3 SA-chelatable lead were similar to those for blood lead.

4 an the other two Asian subgroups, except for blood lead.

5 NPs affecting ALAD expression did not affect blood lead.

6 5% confidence interval (CI): 1.63, 1.70) for blood lead, 0.44 microg/L (95% CI: 0.42, 0.47) for blood

7 An interquartile increment in blood lead (2.8 microg/dl) was associated with 14% highe

8 mosome 9, showed consistent association with blood lead across countries and evidence for multiple in

9 The association between blood lead and blood pressure was stronger among persons

10 tively assessed the association between both blood lead and bone lead, analyzed with the use of K-she

11 D, in a prospective cohort study, using both blood lead and bone lead-a biomarker of cumulative lead

12 Blood lead and bone turnover may be associated with the

13 We examined associations of blood lead and cadmium (n = 6,796) and urine cadmium (n

14 Adjusting for blood lead and cadmium levels reduced this odds ratio to

15 ned by confounding due to smoking, increased blood lead and cadmium levels, and impaired renal functi

16 dults, the highest (vs. lowest) quartiles of blood lead and cadmium were associated with 1.70 (95% CI

17 Blood lead and cadmium, at levels well below current saf

18 There was no association between blood lead and cancer mortality in this range of exposur

19 ntrol studies suggest an association between blood lead and essential tremor, and that this associati

20 Associations of survival time with blood lead and plasma biomarkers of bone resorption (C-t

21 controls to examine the association between blood lead and the risk of amyotrophic lateral sclerosis

22 Few studies have compared associations of blood lead and tibia lead with blood pressure and hypert

23 race/ethnicity) to evaluate associations of blood lead and tibia lead with systolic and diastolic bl

24 ealed associations of current lead exposure (blood lead) and past lead exposure (bone lead) with risk

25 variate analyses were performed with survey, blood lead, and environmental data.

26 tion rates through retrospective analyses of blood lead biomonitoring from the Bunker Hill Superfund

27 Biomarker data (blood cadmium, blood lead, blood mercury, urinary total arsenic, and ur

28 hites exhibit different associations between blood lead (BPb) and blood pressure (BP) and whether dep

29 We evaluated the association between blood lead (BPb) and urine arsenic (As), Cd, molybdenum

30 iron and EDTA, alone and in combination, on blood lead (BPb) concentration, iron status, and cogniti

31 significantly and positively associated with blood lead but only among postmenopausal women not using

32 There was no association between blood lead concentration and LTL.

33 We analyzed the relations between blood lead concentration and pubertal development among

34 Increased blood lead concentration as a function of fragmentation

35 is genetic variation between individuals in blood lead concentration but the polymorphisms contribut

36 rmed a previously reported U-shaped curve in blood lead concentration during pregnancy as well as fin

37 Elevated blood lead concentration during the neonatal period was

38 the median (+/-SD) increase from baseline in blood lead concentration for the supplemented group was

39 he trial, with an overall median increase in blood lead concentration from baseline to month 9 of 0.1

40 Mean blood lead concentration from birth to 78 months was ass

41 Blood lead concentration has been associated with mortal

42 Mean blood lead concentration was 6.43 microg/dL (SD = 2.64).

43 Elevated mean childhood blood lead concentration was also associated with a sign

44 microg per deciliter in the lifetime average blood lead concentration was associated with a 4.6-point

45 Blood lead concentration was associated with decreased w

46 ation between walking speed and quintiles of blood lead concentration was estimated separately in men

47 The relation between IQ and blood lead concentration was estimated with the use of l

48 The blood lead concentration was inversely and significantly

49 mption, educational level, and hypertension, blood lead concentration was positively and significantl

50 ent scores, an effect that is independent of blood lead concentration, suggesting that it is solely d

51 for child and family characteristics and IQ, blood lead concentrations >/=10 microg/dL vs <8 microg/d

52 lead concentrations <8 microg/dL, those with blood lead concentrations >/=8 microg/dL scored 2-3 poin

53 Compared to children with blood lead concentrations <8 microg/dL, those with blood

54 ong 13 participants with high umbilical cord blood lead concentrations (>/= 10 mug/dL) than in 42 par

55 /dL) than in 42 participants with lower cord blood lead concentrations (p = 0.08).

56 The association between blood lead concentrations 8-10 microg/dL and cognitive d

57 Despite dramatic declines in children's blood lead concentrations and a lowering of the Centers

58 d the time course and prevalence of elevated blood lead concentrations and associated injury- and pat

59 Examine the relationships between blood lead concentrations and children's intelligence qu

60 y mediated the relationship between elevated blood lead concentrations and later school performance.

61 Mean blood lead concentrations and walking speeds were 2.17 m

62 The significant effect on blood lead concentrations during the first 4 mo was in t

63 y, older mothers showed steeper increases in blood lead concentrations during the latter half of preg

64 We reconstructed blood lead concentrations for the period between 1979 an

65 egated columns in the barrel field, produced blood lead concentrations from 1 to 31 microg/dl.

66 in IQ or school tests between children with blood lead concentrations groups 8-10 and >/=10 microg/d

67 on was also significant among subjects whose blood lead concentrations had never exceeded 0.48 microm

68 We measured blood lead concentrations in 172 children at 6, 12, 18,

69 xists that DMSA is effective in lowering the blood lead concentrations in children with levels betwee

70 Findings support that blood lead concentrations in early childhood, even <10 m

71 time it is labeled for use in children with blood lead concentrations in excess of 45 micrograms/dL.

72 0.19, -0.04; p-trend = 0.005) for women with blood lead concentrations in the highest versus lowest q

73 Q declined by 7.4 points as lifetime average blood lead concentrations increased from 1 to 10 microg

74 Blood lead concentrations of 3 microg per deciliter were

75 Blood lead concentrations were measured when children we

76 Mean baseline whole blood lead concentrations were slightly below the limit

77 For blood lead concentrations, 7.8% of children (n = 105) ha

78 Blood lead concentrations, even those below 10 microg pe

79 After analysis of blood lead data revealed spiking lead in blood of Flint

80 the coupled model estimates using real-world blood lead data, to quantify relative contributions by t

81 Blood lead determinations were made by atomic absorption

82 The pattern of blood lead during pregnancy was investigated in a cohort

83 Logistic models correctly predicted a blood lead elevation of >/=20 micro g/dl in 81% and 85%

84 nce of miscarriages and fetal death, even at blood lead elevations ( approximately 5 mug/dL) once con

85 llected from condors indicate lead exposure (blood lead >/= 200 ng/mL) that causes significant subcli

86 ns of participants in the highest tertile of blood lead (> or = 0.17 micromol/L [> or = 3.62 microg/d

87 mic status, each 5-microg/dL higher level of blood lead in childhood was associated with a 1.61-point

88 onfounders, each 5-microg/dL higher level of blood lead in childhood was associated with a 1.79-unit

89 However, the prevalence of elevated blood lead in children (>/= 10 mug/dL) remains high in s

90 rnal blood lead including the geometric mean blood lead in DC children (R(2) = 0.68) and the incidenc

91 lopmental assessment scores and decreases in blood lead in iron-replete children with lead poisoning

92 We demonstrate that low levels of blood lead, in the range seen in many impoverished inner

93 to 2007 correlated with proxies for maternal blood lead including the geometric mean blood lead in DC

94 Infant blood lead level (3.4+/-2.2 mug/dL) increased by 1.8 mug

95 childhood lead poisoning [>/= 1 child with a blood lead level (BLL) >/= 10 microg/dL] and lead contam

96 We aimed to report environmental and blood lead level (BLL) in China, and investigate the rel

97 describe and evaluate the changes in venous blood lead level (VBLL) associated with DMSA treatment i

98 on intake quintile (<10.9 mg/day) had a mean blood lead level 1.1 microg/dl higher than men in the hi

99 n C intake quintile (<109 mg/day) had a mean blood lead level 1.7 microg/dl higher than men in the hi

100 confirming the association between elevated blood lead level and higher risk of ALS.

101 The relationship between blood lead level and systolic and diastolic hypertension

102 Mean (SD) blood lead level at age 11 years was 10.99 (4.63) microg

103 levels over time to be associated with high blood lead level at the preceding visit.

104 ension increased with increasing quartile of blood lead level compared with quartile 1 (adjusted OR,

105 Blood lead level does not necessarily reflect the total

106 Differences in blood lead level explained some of the differences in ca

107 ntrol and Prevention has defined an elevated blood lead level in children as > or = 10 microg/dl, on

108 The geometric mean blood lead level in study participants was 0.12 micromol

109 the first six months of the trial, the mean blood lead level in the children given succimer was 4.5

110 al exposure limit guidelines (40 microg/dL), blood lead level is positively associated with both syst

111 Blood lead level may be related with CVD in healthy olde

112 A 10-fold increase in blood lead level predicted an increase of 7 micromol/L (

113 ldren (6 months to 12 years old) for routine blood lead level surveillance March-May 1993 were assaye

114 which produced a distorted notion about the blood lead level that can be considered "normal"; the pr

115 , in multivariable models, a 50% increase in blood lead level was associated with 26% increased odds

116 s, a 0.24-micromol/L (5-microg/dL) change in blood lead level was associated with an elevated risk of

117 Blood lead level was significantly associated with both

118 The log of blood lead level was significantly associated with the n

119 Blood lead level was the principal exposure variable.

120 Associations of childhood blood lead level with deficits in verbal comprehension a

121 st showed a 3.7% (0.5-microg/dl) decrease in blood lead level with each higher category of tofu intak

122 ddition, the magnitude of the association of blood lead level with TNF-R2 level increased with age in

123 There were positive associations of blood lead level with total cholesterol and HDL levels,

124 for sociodemographic factors, birth weight, blood lead level, and tobacco smoke exposure, black carb

125 lower HRT, adjusting for child IQ, age, sex, blood lead level, maternal education, pre- and postnatal

126 bone turnover were significant predictors of blood lead level.

127 phic region, frequency of dental visits, and blood lead level.

128 No association was found with blood lead level.

129 approximately 20% of free-flying birds have blood lead levels (>/=450 ng/mL) that indicate the need

130 th pitcher pumps may be at risk for elevated blood lead levels (>5 mug/dL).

131 ted with significantly lower adjusted median blood lead levels (1.8 microg/dl) than past use (2.6 mic

132 Four different blood lead levels (15 microg/dl, 20 microg/dl, 30 microg

133 number of children under age 6 y of age with blood lead levels (BLL) >/=10mug/dL is estimated at over

134 vitro bioaccessibility assay, and children's blood lead levels (BLL) were investigated in an urban ne

135 10 microg/dL); 97% (198/204) of children had blood lead levels (BLLs) >/= 45 microg/dL, the threshold

136 l study, we examined the association between blood lead levels (BLLs) and GFR measured by the plasma

137 However, the association between blood lead levels (BLLs) and insulin-like growth factor

138 ng water lead concentrations keep children's blood lead levels (BLLs) below specified values, conside

139 concentrations of soil and Pb aerosols, and blood lead levels (BLLs) in 367839 children (ages 0-10)

140 Elevated blood lead levels (BLLs) in young children are also asso

141 Blood lead levels (BLLs) less than 1.21 micromol/L (<25

142 ilable lead from these sources to children's blood lead levels (BLLs) monitored during cleanup from 1

143 ths (0.5%) and 57 adults (0.4%) had elevated blood lead levels (defined as > or =0.72 micromol/L [15

144 est tofu intake group (> or =750 g/week) had blood lead levels 11.3% lower (95% confidence interval:

145 Blood lead levels above 0.48 micromol/L (10 microg/dL) i

146 D analysis was only evident among those with blood lead levels above the median.

147 authors recommend continued surveillance of blood lead levels after gunshot injury for patients with

148 independently associated with decreased log blood lead levels among adults (P<.001), but not among y

149 iations of bone density-related factors with blood lead levels among women aged 40-59 years from the

150 ther dietary tofu intake was associated with blood lead levels among young adults in Shenyang, China.

151 An association between greater blood lead levels and a decline in IQ and socioeconomic

152 ALAD-2 allele has been associated with high blood lead levels and has been thought to increase the r

153 The association between blood lead levels and increased all-cause and cardiovasc

154 They determined blood lead levels at mean time points of 0.3, 3.1, 18.7,

155 New evidence regarding the blood lead levels at which morbidities occur have led to

156 udy was to determine the association between blood lead levels below 0.48 micromol/L and mortality in

157 neuropsychological function in children with blood lead levels below 45 microg per deciliter.

158 Treatment with succimer lowered blood lead levels but did not improve scores on tests of

159 65% to 68% decreased prevalence of elevated blood lead levels compared with adults in the lowest ser

160 had an 89% decreased prevalence of elevated blood lead levels compared with youths in the lowest ser

161 Pre-chelation geometric mean blood lead levels for children </= 5 years old decreased

162 However, workers who had elevated blood lead levels for more than 5 years had a higher ris

163 ps, and health department data on children's blood lead levels from the first 4 years of implementati

164 A change in blood lead levels from the lowest (quartile 1: range, 0.

165 Persons with blood lead levels greater than or equal to the cutoff le

166 Children's blood lead levels have declined worldwide, especially af

167 nsity was significantly inversely related to blood lead levels in log-linear multivariate models that

168 eveloped a regression model to estimate mean blood lead levels in our population of interest, represe

169 ad stored in bone may significantly increase blood lead levels in perimenopausal women because of pos

170 and although there has been some lowering of blood lead levels in recent years, the levels continue t

171 Blood lead levels in the range currently considered acce

172 sponse relation between tofu consumption and blood lead levels in this Chinese population.

173 on during pregnancy as well as findings that blood lead levels increase with age, smoking, lower educ

174 In mixed-model analyses, blood lead levels increased with time postinjury (p < 0.

175 Childhood lead exposure ascertained as blood lead levels measured at age 11 years.

176 We enrolled 780 children with blood lead levels of 20 to 44 microg per deciliter (1.0

177 r detecting disease clustering using data on blood lead levels of children who were patients at the K

178 o examine age and secular trends in bone and blood lead levels of community-exposed men.

179 Despite the marked decrease in blood lead levels over the past 3 decades, environmental

180 It is not known whether treatment to reduce blood lead levels prevents or reduces such impairment.

181 Blood lead levels ranged from < 1 to 27.9 micrograms/dl,

182 ortality was observed at substantially lower blood lead levels than previously reported.

183 gically menopausal women had adjusted median blood lead levels that were 25% and 30% higher, respecti

184 Geometric mean prenatal and postnatal blood lead levels were 1.9 micro g/dl (geometric SD +3.6

185 Mean blood lead levels were 13.2 microg/dl in men and 10.1 mi

186 Blood lead levels were also measured.

187 Blood lead levels were higher among cases compared with

188 Blood lead levels were low, ranging from less than 0.05

189 Blood lead levels were measured in a nationally represen

190 Bone and blood lead levels were measured twice, with a 3-year int

191 Blood lead levels were negatively associated with tofu i

192 High blood lead levels were observed among children from all

193 Questionnaire data and serial blood lead levels were obtained from 105 participants (6

194 ears) with repeated measurements of bone and blood lead levels were studied.

195 These bone and blood lead levels were typical of those of community-exp

196 ndia should note the association of elevated blood lead levels with anemia and make further efforts t

197 uthors also observed inverse associations of blood lead levels with total dietary intake of vitamin C

198 ests that were significantly associated with blood lead levels, an increase in blood lead of 5 microg

199 pertension medications, including diuretics, blood lead levels, and hyperlipidemia, the odds ratios o

200 ls (measured by K-shell x-ray fluorescence), blood lead levels, and hypertension.

201 r pack-years of cigarette smoking, diabetes, blood lead levels, and intake of vitamin C, vitamin E, a

202 Blood lead levels, more indicative of short-term exposur

203 mately 10 times as high as the corresponding blood lead levels, suggesting that lead is being concent

204 hat postmenopausal bone resorption increases blood lead levels, the authors examined cross-sectional

205 environmentally exposed population with low blood lead levels.

206 .0005) or near joints (p = 0.032) had higher blood lead levels.

207 positive) were significantly associated with blood lead levels.

208 apy is not indicated for children with these blood lead levels.

209 ts can document a low prevalence of elevated blood lead levels.

210 ated with a decreased prevalence of elevated blood lead levels.

211 ronmental ones, are important in determining blood lead levels.

212 kers, although there is some suggestion that blood lead may be associated with tremor among the young

213 ho completed baseline questionnaires and had blood lead measurements taken in 1996-1998 as part of a

214 n = 670) and patella (n = 672) bone lead and blood lead (n = 807) among older men (age range, 50-98 y

215 3-56 micrograms/g) corresponded to a rise in blood lead of 4.3 micrograms/dl.

216 iated with blood lead levels, an increase in blood lead of 5 microg/dl was equivalent to an increase

217 ssociated with a 1.7- micro g/dl increase in blood lead (p = 0.0001) in this group.

218 years), tremor increased significantly with blood lead (p = 0.03), but this pattern was not apparent

219 n, along with other neurotoxicants including blood lead (Pb) and serum cotinine, and child cognition.

220 this work is to examine associations between blood lead (PbB) and air lead (PbA) in particulate matte

221 It is difficult to discern the proportion of blood lead (PbB) attributable to ambient air lead (PbA),

222 Blood lead, plasma biomarkers of bone formation (procoll

223 Blood lead, plasma CTX, and plasma PINP were mutually ad

224 ification of genetic polymorphisms affecting blood lead reinforces the view that genetic factors, as

225 iation in the strength of the blood pressure-blood lead relation that has been observed in previous s

226 speed decreased with increasing quintiles of blood lead, resulting in an estimated mean value that wa

227 Blood lead screening is recommended either universally a

228 one lead with estrogen status in determining blood lead supports the hypothesis that increased bone r

229 In the final model predicting blood lead that began with these same covariates and als

230 rs, chronic kidney disease risk factors, and blood lead, the odds ratios for albuminuria (>or=30 mg/g

231 ional study to evaluate associations between blood lead, tibia lead, and dimercaptosuccinic acid (DMS

232 Means (standard deviations) for blood lead, tibia lead, and patella lead were 6.2 (4.1)

233 etary sodium intake, dietary calcium intake, blood lead, tibia lead, and patella lead, the variables

234 The relations of bone lead and blood lead to breast milk lead were modified by breastfe

235 ted that isolation of human neutrophils from blood leads to a spontaneous increase in their plasminog

236 control elevated phenylalanine levels in the blood leads to increased risk of mental disabilities com

237 Activation of human MAIT cells in whole blood leads to MR1- and cytokine-dependent NK cell trans

238 lations we demonstrated that the addition of blood led to a differential expression of 154 genes.

239 n-lineage ZIKV infection of pregnant women's blood led to an exacerbated M2-skewed immunosuppression

240 Transfusion with old but not new blood led to intravascular hemolysis, acute hypertension

241 in skin areas, which are well supplied with blood, lead to more severe reactions and tested our hypo

242 tumors more rapidly and quickly cleared from blood, leading to a lower overall normal tissue exposure

243 in vivo K-shell X-ray fluorescence and cord blood lead using atomic absorption spectrometry.

244 The prevalence of elevated blood lead was 11.8% at 3 months and 2.6% at 12 months.

245 In these currently exposed workers, blood lead was a better predictor of neurobehavioral per

246 ead were negative for 16 of the 19 tests and blood lead was a significant predictor of worse performa

247 Blood lead was a strong and consistent predictor of both

248 ion with tibia lead was weaker and that with blood lead was absent.

249 Blood lead was analyzed by graphite furnace atomic absor

250 A doubling of blood lead was associated with a 1.9-fold increased risk

251 one lead was not associated with cancer, and blood lead was not associated with any mortality categor

252 -frequency hearing loss (p-trend=0.003), but blood lead was not associated with hearing loss.

253 for the dominant portion of the variance in blood lead was patella lead.

254 ates, the signs of the beta coefficients for blood lead were negative for 16 of the 19 tests and bloo

255 confidence intervals for the association of blood lead with ALS were estimated with unconditional lo